Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 12
63
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Metabolism of benzbromarone in man: structures of new oxidative metabolites, 6-hydroxy- and 1″-oxo-benzbromarone, and the enantioselective formation and elimination of 1″-hydroxybenzbromarone

, , , , , , , & show all
Pages 1435-1450 | Received 20 May 1993, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zihan Hou, Aijinxiu Ma, Jiale Mao, Danni Song & Xu Zhao. (2023) Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-15.
Read now
Frank J. Belas & Ian A. Blair. (2001) MASS SPECTROMETRY IN PHARMACEUTICAL ANALYSIS*. Journal of Liposome Research 11:4, pages 309-342.
Read now

Articles from other publishers (13)

Mineyuki Mizuguchi, Takeshi Yokoyama, Takuya Okada, Yusuke Nakagawa, Kanako Fujii, Yuko Nabeshima & Naoki Toyooka. (2023) Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorganic & Medicinal Chemistry 90, pages 117370.
Crossref
Naoki Cho, Hiroshi Suemizu, Hidetaka Kamimura, Tomoyuki Ohe, Fumi Ito, Hidetaka Akita & Kaoru Kobayashi. (2022) Formation of reactive metabolites of benzbromarone in humanized-liver mice. Drug Metabolism and Pharmacokinetics 47, pages 100467.
Crossref
Naoki Cho, Kaoru Kobayashi, Mina Yoshida, Noriyuki Kogure, Hiromitsu Takayama & Kan Chiba. (2017) Identification of novel glutathione adducts of benzbromarone in human liver microsomes. Drug Metabolism and Pharmacokinetics 32:1, pages 46-52.
Crossref
K. Wang, H. Wang, Y. Peng & J. Zheng. (2016) Identification of Epoxide-Derived Metabolite(s) of Benzbromarone. Drug Metabolism and Disposition 44:4, pages 607-615.
Crossref
Fernando A. Pagliai, Claudio F. Gonzalez & Graciela L. Lorca. (2015) Identification of a Ligand Binding Pocket in LdtR from Liberibacter asiaticus. Frontiers in Microbiology 6.
Crossref
David S. NewcombeDavid S. Newcombe. 2013. Gout. Gout 291 385 .
. (2011) Scientific Opinion on Flavouring Group Evaluation 13, Revision 2 (FGE.13Rev2): Furfuryl and furan derivatives with and without additional side-chain substituents and heteroatoms from chemical group 14. EFSA Journal 9:8, pages 2313.
Crossref
HO JUNG SHIN, MICHIO TAKEDA, ATSUSHI ENOMOTO, MASAAKI FUJIMURA, HIROKI MIYAZAKI, NAOHIKO ANZAI & HITOSHI ENDOU. (2011) Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology 16:2, pages 156-162.
Crossref
. (2010) Scientific Opinion on Flavouring Group Evaluation 13Rev1: Furfuryl and furan derivatives with and without additional side‐chain substituents and heteroatoms from chemical group 14. EFSA Journal 8:4.
Crossref
Matthew G. McDonald & Allan E. Rettie. (2007) Sequential Metabolism and Bioactivation of the Hepatotoxin Benzbromarone: Formation of Glutathione Adducts From a Catechol Intermediate. Chemical Research in Toxicology 20:12, pages 1833-1842.
Crossref
Charles W. Locuson, Hisashi Suzuki, Allan E. Rettie & Jeffrey P. Jones. (2004) Charge and Substituent Effects on Affinity and Metabolism of Benzbromarone-Based CYP2C19 Inhibitors. Journal of Medicinal Chemistry 47:27, pages 6768-6776.
Crossref
Charles W. LocusonIIII, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock & Jeffrey P. Jones. (2003) A NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVES. Drug Metabolism and Disposition 31:7, pages 967-971.
Crossref
Kimiyoshi Ichida, Makoto Hosoyamada, Hiroaki Kimura, Michio Takeda, Yasunori Utsunomiya, Tatsuo Hosoya & Hitoshi Endou. (2003) Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney International 63:1, pages 143-155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.